Faculty:

Steven Elias, MD, FACS
Director Center for Vein Disease
Assistant Clinical Professor of Surgery
Mt. Sinai School of Medicine
Englewood Hospital and Medical Center
Englewood, NJ

Randy Shafritz, MD
Assistant Professor of Surgery
Robert Wood Johnson
Jersey Shore University Medical Center
Riverview Medical Center
West Long Branch, NJ

---

Target Audience:

This educational activity has been developed for physicians and podiatrists.

---

Fee Information:

There is no fee for this educational activity.

---

Learning Objectives:

Upon completion of this educational activity, participants should be able to:

• Discuss the pathophysiology of venous disease
  
• Discuss how treatment options have changed and describe advances in technology and treatment of venous diseases
  
• Define abnormalities in wound healing
  
• Discuss how and why cell therapy works in treatment
  
• List the indications for use of cell therapy in treatment of ulcers
  

---

Accreditation:

MD/DO:
This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The North American Center for Continuing Medical Education designates this continuing medical education activity for a maximum of 1 AMA PRA Category 1 Credit(s) ™ Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.

Podiatrists:
The North American Center for Continuing Medical Education (NACCME) is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine.

This program is approved for 1 continuing education contact hour(s)

---

Faculty Disclosures:

All faculty participating in Continuing Education programs sponsored by the North American Center for Continuing Medical Education are expected to disclose to the meeting audience any real or apparent conflict(s) of interest related to the content of their presentation. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants.

Doctor Shafritz has disclosed that he is a member of the speakers’ bureau for Organogenesis.

Doctor Elias has disclosed that he is a consultant to Diomed Inc.and Luminetx Inc.

All faculty participating in Continuing Education programs sponsored by the North American Center for Continuing Medical Education are expected to disclose to the meeting audience any real or apparent conflict(s) of interest related to the content of their presentation. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations. Full faculty disclosure will be made at the beginning of the activity.

---

Commercial Supporter:

This activity is supported by an educational grant from Organogenesis.

---

Sponsor:

Sponsored by the North American Center for Continuing Medical Education (NACCME).